The impact of Chemotherapy cycle ≥11 (HR = 2.65(0.80–8.80), p = 0.112) on VTE risk did not reach statistical significance.
← all excerpts
Development and validation of a nomogram model for predicting the risk of venous thromboembolism in lymphoma patients undergoing chemotherapy: a prospective cohort study conducted in China.
1
—
—